• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Regulatory Affairs Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global regulatory affairs outsourcing market grew at a CAGR of around 10% during 2015-2020. Regulatory affairs outsourcing refers to the hiring of third-party services by the government bodies and private organizations to ensure public health and safety. The services include managing regulatory requirements for generic drugs, innovator drugs, biologics, biosimilars, etc. The outsourcing organizations control the safety and efficacy of the products and ensure that they are safe for consumption. These services are required for clinical trial and patent application, regulatory writing and publishing, product registration and legal representation. Pharmaceutical organizations also opt for these services to seek speedy government approvals in various regions.

Significant growth in the pharmaceutical and biotechnological industries across the globe represents one of the key factors creating a positive outlook for the market. Furthermore, the increasing emphasis of pharmaceutical organizations to expand their operations and supplies in the emerging economies is also driving the market growth. Outsourcing regulatory affairs also aid in minimizing the costs associated with managing in-house resources, such as facilities, training, technology, specialized knowledge and geographic regulations. Additionally, regulatory affairs outsourcing services are also widely used for the development of biosimilar, orphan and generic drugs, which is acting as another major growth-inducing factor. Life science organizations are increasingly outsourcing non-core functions and regulatory services and increase their overall operational efficiencies, which, in turn, is contributing to the market growth. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to drive the market further. Looking forward, IMARC Group expects the global regulatory affairs outsourcing market to exhibit strong growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global regulatory affairs outsourcing market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, services, company size, category, indication, stage and end user.

Breakup by Services:

  • Regulatory Consulting
  • Legal Representation
  • Regulatory Writing and Publishing
  • Product Registration and Clinical Trial Applications
  • Others
     

Breakup by Company Size:

  • Small
  • Medium
  • Large 
     

Breakup by Category:

  • Generic Drugs
  • Innovator Drugs
  • Biologic Drugs
  • Biosimilars
  • Medical Devices
    • Therapeutic
    • Diagnostic
  • Others
     

Breakup by Indication:

  • Oncology
  • Neurology
  • Cardiology
  • Immunology
  • Others
     

Breakup by Stage:

  • Preclinical
  • Clinical
  • PMA (Post Market Authorization)
     

Breakup by End User:

  • Medical Device Companies
  • Pharmaceutical Companies
  • Biotechnology Companies
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International, Inc., Covance Inc (Laboratory Corporation of America Holdings), Freyr, ICON Plc, Medpace Holdings Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, Promedica International- A California Corporation and Wuxi AppTec Co. Ltd.

Key Questions Answered in This Report:

  • How has the global regulatory affairs outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global regulatory affairs outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the services?
  • What is the breakup of the market based on the company size?
  • What is the breakup of the market based on the category?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the stage?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global regulatory affairs outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Regulatory Affairs Outsourcing Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Services
    6.1   Regulatory Consulting
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2   Legal Representation
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3   Regulatory Writing and Publishing
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4   Product Registration and Clinical Trial Applications
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5   Others
        6.5.1 Market Trends
        6.5.2 Market Forecast
7    Market Breakup by Company Size
    7.1   Small
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2   Medium
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3   Large 
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Category
    8.1   Generic Drugs
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2   Innovator Drugs
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3   Biologic Drugs
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4   Biosimilars
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5   Medical Devices
        8.5.1 Market Trends
        8.5.2 Major Types
            8.5.2.1 Therapeutic
            8.5.2.2 Diagnostic
        8.5.3 Market Forecast
    8.6   Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9    Market Breakup by Indication
    9.1   Oncology
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2   Neurology
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3   Cardiology
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4   Immunology
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5   Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Stage
    10.1   Preclinical
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2   Clinical
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3   PMA (Post Market Authorization)
        10.3.1 Market Trends
        10.3.2 Market Forecast
11    Market Breakup by End User
    11.1   Medical Device Companies
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2   Pharmaceutical Companies
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3   Biotechnology Companies
        11.3.1 Market Trends
        11.3.2 Market Forecast
12    Market Breakup by Region
    12.1   North America
        12.1.1   United States
            12.1.1.1 Market Trends
            12.1.1.2 Market Forecast
        12.1.2   Canada
            12.1.2.1 Market Trends
            12.1.2.2 Market Forecast
    12.2   Asia-Pacific
        12.2.1   China
            12.2.1.1 Market Trends
            12.2.1.2 Market Forecast
        12.2.2   Japan
            12.2.2.1 Market Trends
            12.2.2.2 Market Forecast
        12.2.3   India
            12.2.3.1 Market Trends
            12.2.3.2 Market Forecast
        12.2.4   South Korea
            12.2.4.1 Market Trends
            12.2.4.2 Market Forecast
        12.2.5   Australia
            12.2.5.1 Market Trends
            12.2.5.2 Market Forecast
        12.2.6   Indonesia
            12.2.6.1 Market Trends
            12.2.6.2 Market Forecast
        12.2.7   Others
            12.2.7.1 Market Trends
            12.2.7.2 Market Forecast
    12.3   Europe
        12.3.1   Germany
            12.3.1.1 Market Trends
            12.3.1.2 Market Forecast
        12.3.2   France
            12.3.2.1 Market Trends
            12.3.2.2 Market Forecast
        12.3.3   United Kingdom
            12.3.3.1 Market Trends
            12.3.3.2 Market Forecast
        12.3.4   Italy
            12.3.4.1 Market Trends
            12.3.4.2 Market Forecast
        12.3.5   Spain
            12.3.5.1 Market Trends
            12.3.5.2 Market Forecast
        12.3.6   Russia
            12.3.6.1 Market Trends
            12.3.6.2 Market Forecast
        12.3.7   Others
            12.3.7.1 Market Trends
            12.3.7.2 Market Forecast
    12.4   Latin America
        12.4.1   Brazil
            12.4.1.1 Market Trends
            12.4.1.2 Market Forecast
        12.4.2   Mexico
            12.4.2.1 Market Trends
            12.4.2.2 Market Forecast
        12.4.3   Others
            12.4.3.1 Market Trends
            12.4.3.2 Market Forecast
    12.5   Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13    SWOT Analysis
    13.1   Overview
    13.2   Strengths
    13.3   Weaknesses
    13.4   Opportunities
    13.5   Threats
14    Value Chain Analysis
15    Porters Five Forces Analysis

    15.1   Overview
    15.2   Bargaining Power of Buyers
    15.3   Bargaining Power of Suppliers
    15.4   Degree of Competition
    15.5   Threat of New Entrants
    15.6   Threat of Substitutes
16    Price Analysis
17    Competitive Landscape

    17.1   Market Structure
    17.2   Key Players
    17.3   Profiles of Key Players
        17.3.1   Charles River Laboratories International Inc.
            17.3.1.1 Company Overview
            17.3.1.2 Product Portfolio
            17.3.1.3 Financials
            17.3.1.4 SWOT Analysis
        17.3.2   Covance Inc (Laboratory Corporation of America Holdings)
            17.3.2.1 Company Overview
            17.3.2.2 Product Portfolio
            17.3.2.3 SWOT Analysis
        17.3.3   Freyr
            17.3.3.1 Company Overview
            17.3.3.2 Product Portfolio
        17.3.4   ICON Plc
            17.3.4.1 Company Overview
            17.3.4.2 Product Portfolio
            17.3.4.3 Financials
            17.3.4.4 SWOT Analysis
        17.3.5   Medpace Holdings Inc
            17.3.5.1 Company Overview
            17.3.5.2 Product Portfolio
            17.3.5.3 Financials
            17.3.5.4 SWOT Analysis
        17.3.6   Parexel International Corporation
            17.3.6.1 Company Overview
            17.3.6.2 Product Portfolio
            17.3.6.3 SWOT Analysis
        17.3.7   Pharmaceutical Product Development LLC
            17.3.7.1 Company Overview
            17.3.7.2 Product Portfolio
            17.3.7.3 Financials
            17.3.7.4 SWOT Analysis
        17.3.8   Promedica International- A California Corporation
            17.3.8.1 Company Overview
            17.3.8.2 Product Portfolio
        17.3.9   Wuxi AppTec Co. Ltd.
            17.3.9.1 Company Overview
            17.3.9.2 Product Portfolio

List of Figures

Figure 1: Global: Regulatory Affairs Outsourcing Market: Major Drivers and Challenges
Figure 2: Global: Regulatory Affairs Outsourcing Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Regulatory Affairs Outsourcing Market: Breakup by Services (in %), 2020
Figure 5: Global: Regulatory Affairs Outsourcing Market: Breakup by Company Size (in %), 2020
Figure 6: Global: Regulatory Affairs Outsourcing Market: Breakup by Category (in %), 2020
Figure 7: Global: Regulatory Affairs Outsourcing Market: Breakup by Indication (in %), 2020
Figure 8: Global: Regulatory Affairs Outsourcing Market: Breakup by Stage (in %), 2020
Figure 9: Global: Regulatory Affairs Outsourcing Market: Breakup by End User (in %), 2020
Figure 10: Global: Regulatory Affairs Outsourcing Market: Breakup by Region (in %), 2020
Figure 11: Global: Regulatory Affairs Outsourcing (Regulatory Consulting) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Regulatory Affairs Outsourcing (Regulatory Consulting) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Regulatory Affairs Outsourcing (Legal Representation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Regulatory Affairs Outsourcing (Legal Representation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Regulatory Affairs Outsourcing (Regulatory Writing and Publishing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Regulatory Affairs Outsourcing (Regulatory Writing and Publishing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Regulatory Affairs Outsourcing (Product Registration and Clinical Trial Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Regulatory Affairs Outsourcing (Product Registration and Clinical Trial Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Regulatory Affairs Outsourcing (Other Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Regulatory Affairs Outsourcing (Other Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Regulatory Affairs Outsourcing (Small) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Regulatory Affairs Outsourcing (Small) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Regulatory Affairs Outsourcing (Medium) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Regulatory Affairs Outsourcing (Medium) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Regulatory Affairs Outsourcing (Large ) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Regulatory Affairs Outsourcing (Large ) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Regulatory Affairs Outsourcing (Generic Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Regulatory Affairs Outsourcing (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Regulatory Affairs Outsourcing (Innovator Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Regulatory Affairs Outsourcing (Innovator Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Regulatory Affairs Outsourcing (Biologic Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Regulatory Affairs Outsourcing (Biologic Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Regulatory Affairs Outsourcing (Biosimilars) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Regulatory Affairs Outsourcing (Biosimilars) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Regulatory Affairs Outsourcing (Medical Devices) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Regulatory Affairs Outsourcing (Medical Devices) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Regulatory Affairs Outsourcing (Other Categories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Regulatory Affairs Outsourcing (Other Categories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Regulatory Affairs Outsourcing (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Regulatory Affairs Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Regulatory Affairs Outsourcing (Neurology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Regulatory Affairs Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Global: Regulatory Affairs Outsourcing (Cardiology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Global: Regulatory Affairs Outsourcing (Cardiology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Global: Regulatory Affairs Outsourcing (Immunology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Global: Regulatory Affairs Outsourcing (Immunology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Global: Regulatory Affairs Outsourcing (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Global: Regulatory Affairs Outsourcing (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Global: Regulatory Affairs Outsourcing (Preclinical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Global: Regulatory Affairs Outsourcing (Preclinical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Global: Regulatory Affairs Outsourcing (Clinical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Global: Regulatory Affairs Outsourcing (Clinical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Global: Regulatory Affairs Outsourcing (PMA (Post Market Authorization)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Global: Regulatory Affairs Outsourcing (PMA (Post Market Authorization)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Global: Regulatory Affairs Outsourcing (Medical Device Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Global: Regulatory Affairs Outsourcing (Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Global: Regulatory Affairs Outsourcing (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Global: Regulatory Affairs Outsourcing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Global: Regulatory Affairs Outsourcing (Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Global: Regulatory Affairs Outsourcing (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: North America: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: North America: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: North America: Regulatory Affairs Outsourcing Market: Breakup by Country (in %), 2020
Figure 64: United States: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: United States: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Canada: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Canada: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Asia-Pacific: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Asia-Pacific: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Asia-Pacific: Regulatory Affairs Outsourcing Market: Breakup by Country (in %), 2020
Figure 71: China: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: China: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Japan: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Japan: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: India: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: India: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: South Korea: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: South Korea: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Australia: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Australia: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Indonesia: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Indonesia: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Others: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Others: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Europe: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Europe: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Europe: Regulatory Affairs Outsourcing Market: Breakup by Country (in %), 2020
Figure 88: Germany: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 89: Germany: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 90: France: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 91: France: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 92: United Kingdom: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 93: United Kingdom: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 94: Italy: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 95: Italy: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 96: Spain: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 97: Spain: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 98: Russia: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 99: Russia: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 100: Others: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 101: Others: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 102: Latin America: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 103: Latin America: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 104: Latin America: Regulatory Affairs Outsourcing Market: Breakup by Country (in %), 2020
Figure 105: Brazil: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 106: Brazil: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 107: Mexico: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 108: Mexico: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 109: Others: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 110: Others: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 111: Middle East and Africa: Regulatory Affairs Outsourcing Market: Sales Value (in Million US$), 2015 & 2020
Figure 112: Middle East and Africa: Regulatory Affairs Outsourcing Market: Breakup by Country (in %), 2020
Figure 113: Middle East and Africa: Regulatory Affairs Outsourcing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 114: Global: Regulatory Affairs Outsourcing Industry: SWOT Analysis
Figure 115: Global: Regulatory Affairs Outsourcing Industry: Value Chain Analysis
Figure 116: Global: Regulatory Affairs Outsourcing Industry: Porter's Five Forces Analysis
Figure 117: Global: Regulatory Affairs Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Regulatory Affairs Outsourcing Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Services (in Million US$), 2021-2026
Table 3: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Company Size (in Million US$), 2021-2026
Table 4: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Category (in Million US$), 2021-2026
Table 5: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 6: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Stage (in Million US$), 2021-2026
Table 7: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 8: Global: Regulatory Affairs Outsourcing Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 9: Global: Regulatory Affairs Outsourcing Market: Competitive Structure
Table 10: Global: Regulatory Affairs Outsourcing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links